| Literature DB >> 24701242 |
Jaw-Chyun Chen1, Chien-Yun Hsiang2, Yung-Chang Lin3, Tin-Yun Ho4.
Abstract
Deer antler is a well-known traditional Chinese medicine used in Asian countries for the tonic and the improvement of aging symptoms. The present study was designed to investigate the antifatigue effect and mechanism of Formosan sambar deer tip antler extract (FSDTAE). The swimming times to exhaustion of mice administered FSDTAE (8.2 mg/day) for 28 days were apparently longer than those of the vehicle-treated mice in forced swim test. However, the indicators of fatigue, such as the reduction in glucose level and the increases in blood urea nitrogen and lactic acid levels, were not significantly inhibited by FSDTAE. Therefore, microarray analysis was further used to examine the anti-fatigue mechanism of FSDTAE. We selected genes with fold changes >2 or <-2 in skeletal muscle for pathway analysis. FSDTAE-affected genes were involved in 9 different signaling pathways, such as GnRH signaling pathway and insulin signaling pathway. All of the significantly expressed genes were classified into 8 different categories by their functions. The most enriched category was muscular system, and 6 upregulated genes, such as troponin I, troponin T1, cysteine and glycine-rich protein 2, myosin heavy polypeptide 7, tropomyosin 2, and myomesin family member 3, were responsible for the development and contraction of muscle. Real-time PCR analysis indicated that FSDTAE increased troponins mRNA expression in skeletal muscle. In conclusion, our findings suggested that FSDTAE might increase the muscle strength through the upregulation of genes responsible for muscle contraction and consequently exhibited the anti-fatigue effect in mice.Entities:
Year: 2014 PMID: 24701242 PMCID: PMC3950920 DOI: 10.1155/2014/540580
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Cross-sections and SDS-PAGE of antler from different layers. (a) Cross-sections of antler from different layers. (b) Proteins of antler were analyzed by electrophoresis on a 10% SDS-PAGE gel. M: marker; L1: Periosteum of tip antler; L2: sponge bone of tip antler; L3: Periosteum of middle part of antler; L4: sponge bone of middle part of antler; L5: Periosteum of antler base; L6: sponge bone of antler base.
LC/MS/MS identification of specific protein from tip antler.
| Version number | Protein identification | Coverage (%) | Matched peptide Sequences | Taxonomy |
|---|---|---|---|---|
| gi∣254221095 | Single Type I Collagen Molecule, Rigid Body Refinement | 6 | GFSGLDGAK; |
|
|
| ||||
| gi∣426237753 | collagen alpha-1(I) chain | 4 | GFPGSDGVAGPK; |
|
|
| ||||
| gi∣440893297 | Collagen alpha-2(I) chain | 4 | GIPGPVGASGATGAR; |
|
|
| ||||
| gi∣478521049 | collagen alpha-1(I) chain isoform 1 | 3 | GFSGLDGAK; |
|
|
| ||||
| gi∣4960163 | type I collagen pre-pro-alpha1(I) chain | 3 | GETGPAGPAGPIGPVGAR; |
|
|
| ||||
| gi∣524951811 | collagen alpha-1(I) chain isoform X1 | 2 | GFSGLDGAK; |
|
|
| ||||
| gi∣38649122 | Collagen, type I, alpha 1 | 2 | GFPGLPGPSGEIGK; |
|
|
| ||||
| gi∣530624898 | collagen alpha-1(I) chain | 2 | GFSGLDGAK; |
|
|
| ||||
| gi∣426227338 | collagen alpha-2(I) chain | 2 | TGQPGAVGPAGIR; |
|
|
| ||||
| gi∣343887367 | collagen, type I, alpha 2 precursor | 2 | TGQPGAVGPAGIR; GEPGPAGSVGPAGAVGPR; |
|
Figure 2Effects of FSDTAE on swimming time to fatigue in mice. Mice were orally administered FSDTAE or vehicle, and swimming time to fatigue was measured at 28th day. Bars are expressed as an average value in swimming time. Lines are expressed as body weight change. Values are means ± SEM. *P < 0.05, significance between the control and samples.
Figure 3Effects of orally administered FSDTAE on the blood chemical parameters of antifatigue test in mice. Mice were orally administered the FSDTAE or vehicle for 28 consecutive days. Whole blood was collected by retroorbital bleeding from mice for the measurement of lactate (a), BUN (b) and glucose (c). Abbreviations used: BUN, blood urea nitrogen; LAC, lactate; GLU, glucose. Values are means ± SEM.
Pathway analysis revealed that 9 pathways were regulated by FSDTAE in skeletal muscle of mice.
| Pathway | Gene no. | FDR |
|---|---|---|
| Citrate cycle | 26 | 3.42 |
| Prolactin signaling pathway | 10 | 5.09 |
| Adipocytokine signaling pathway | 69 | 1.76 |
| Insulin signaling pathway | 133 | 2.14 |
| Tight junction | 113 | 2.35 |
| Serum response factor mediated pathway | 10 | 5.20 |
| GnRH signaling pathway | 92 | 6.25 |
| Adherens junction | 73 | 6.56 |
| IGF signaling pathway | 38 | 1.14 |
The expressed genes that were up- or downregulated in the skeletal muscle of FSDTAE-treated group compared with the vehicle group.
| Function | Symbol | Gene description | Fold change |
|---|---|---|---|
| Muscular system | Myom3 | Mus musculus myomesin family, member 3 | 4.25 |
| Csrp2 | Cysteine and glycine-rich protein 2 | 2.47 | |
| Tnni1 | troponin I, skeletal, slow 1 | 2.38 | |
| Tnnt1 | troponin T1, skeletal, slow | 2.29 | |
| Myh7 | myosin, heavy polypeptide 7, cardiac muscle, beta | 2.21 | |
| Tpm2 | tropomyosin 2, beta | 2.17 | |
| Actc1 | actin, alpha, cardiac muscle 1 | −2.06 | |
| Crip2 | Cysteine-rich protein 2 | −2.32 | |
| HSC70a | Heat shock protein 8 | −2.82 | |
| Pln | Phospholamban | −2.83 | |
| Tnni3 | troponin I, cardiac 3 | −4.85 | |
| Myh6 | myosin, heavy polypeptide 6, cardiac muscle, alpha | −7.13 | |
|
| |||
| Nervous system development and function | Vps13a | vacuolar protein sorting 13A (chorein) | 15.30 |
|
| |||
| Energy metabolism | Car3 | Carbonic anhydrase 3 | 2.14 |
| Car3 | Carbonic anhydrase 3 | 2.08 | |
|
| |||
| Epithelial development and differentiation | Krt10 | Keratin, type I cytoskeletal 10 | 2.75 |
| Krt10 | Keratin, type I cytoskeletal 10 | 2.35 | |
| Sbsn | suprabasin isoform 1 | 2.02 | |
|
| |||
| Cellular growth and proliferation | Pwp2 | Periodic tryptophan protein 2 homolog | 5.15 |
| Rarres2 | Retinoic acid receptor responder 2 | 2.58 | |
| CRBP-II | Cellular retinoic acid-binding protein-II | −2.07 | |
| Spry2 | Sprouty homolog 2 (Drosophila) | −3.58 | |
|
| |||
| Immune response | C3 | Complement component 3 | 4.07 |
| C2 | Complement component 2 | 2.45 | |
|
| |||
| Miscellaneous genes | Rnu22 | Mus musculus small nucleolar RNA | 21.85 |
| Targ3 | transforming growth factor alpha regulated gene 3 | 12.53 | |
| TSEG-2 | testis-specific expressed protein 2 | 12.14 | |
| Tmem165 | Transmembrane protein 165 | 3.54 | |
| Hoxc6 | Homeo box C6 | 3.06 | |
| Eras | ES cell-expressed Ras | 2.9 | |
| Olfr1018 | Olfactory receptor 1018 | 2.9 | |
| Serpina1a | Serine peptidase inhibitor, clade A, member 1a | 2.34 | |
| Rbp2 | Retinol binding protein 2, cellular | −2.07 | |
| Ptgds | Prostaglandin D2 synthase (brain) | −2.11 | |
| Atxn7 | ataxin 7 | −2.41 | |
| Ube2ql1 | ubiquitin-conjugating enzyme E2Q family-like 1 | −2.41 | |
| Ankrd13d | Ankyrin repeat domain-containing protein 13D | −2.94 | |
| Magee1 | Melanoma antigen, family E, 1 | −4.97 | |
| Paip2b | poly(A) binding protein interacting protein 2B | −24.46 | |
|
| |||
| Unknown function | D1Ertd622e | hypothetical protein LOC52392 | 9.87 |
| 5430409L15Rik | RIKEN cDNA 5430409L15 gene | 2.81 | |
| 1810006K21Rik | Mus musculus RIKEN cDNA 1810006K21 gene | 2.3 | |
| A330009N23Rik | RIKEN cDNA A330009N23 gene | −2.13 | |
| Hddc2 | HD domain-containing protein 2 | −7.28 | |
| A630083H20Rik | RIKEN cDNA A630083H20 gene | −10.18 | |
aOther designation Hspa.
Figure 4Real-time PCR confirmation of transcript levels of troponins in skeletal muscle samples of FSDTAE-treated and vehicle-treated mice. Average fold elevation of troponins detected in both FSDTAE-treated and vehicle-treated mice skeletal muscle samples by microarray hybridization (white) or real-time RT-PCR (stripe).
Figure 5Hypothesis of the mechanism of how deer antler extract to improve the fatigue effects.